40 participants
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-04
- Start Date:
- 2024-03-07
- Completion:
- 2028-12-31
Conditions
- Acute Myeloid Leukemia
Interventions
- DRUG
No Results Yet